NIH funding by institute · Fiscal year 2026
National Heart, Lung, and Blood Institute (NHLBI) Grants and Funding
Reviewed by Dr. Meng ZhaoLast reviewed October 26, 2026Data refreshed October 16, 2026Editorial standards
NHLBI administered $3.12B in fiscal year 2026 across 5,269 award records to 244 institutions with $10M or more in NIH funding, down 2.6% from FY2025. University of Pittsburgh received the most, 2.5% of that total.
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
FY2026 NHLBI funding
$3.12B
−2.6% vs FY2025
Award records
5,269
Institutions funded
244
Recipients with $10M+ in NIH funding
Open or upcoming NOFOs
77
NHLBI as lead or participating institute
Top NHLBI-funded institutions, FY2026
| # | Institution | NHLBI FY2026 | vs FY2025 | Awards | Share |
|---|---|---|---|---|---|
| 1 | University of PittsburghPittsburgh, PA | $77.7M | −0.3% | 138 | 2.5% |
| 2 | University of PennsylvaniaPhiladelphia, PA | $76.0M | −1.3% | 149 | 2.4% |
| 3 | Northwestern UniversityChicago, IL | $75.5M | +18.2% | 97 | 2.4% |
| 4 | Johns Hopkins UniversityBaltimore, MD | $73.9M | −8.9% | 152 | 2.4% |
| 5 | University of MichiganAnn Arbor, MI | $73.0M | −6.5% | 138 | 2.3% |
| 6 | University of California, San FranciscoSan Francisco, CA | $71.4M | −6.8% | 139 | 2.3% |
| 7 | Brigham and Women's HospitalBoston, MA | $70.5M | −11.0% | 114 | 2.3% |
| 8 | Stanford UniversityStanford, CA | $67.5M | −14.9% | 140 | 2.2% |
| 9 | Massachusetts General HospitalBoston, MA | $64.1M | −6.8% | 110 | 2.1% |
| 10 | University of North Carolina at Chapel HillChapel Hill, NC | $62.7M | +11.5% | 104 | 2.0% |
| 11 | Westat, Inc.Bethesda, MD | $62.3M | −34.0% | 2 | 2.0% |
| 12 | Vanderbilt University Medical CenterNashville, TN | $61.9M | −7.6% | 91 | 2.0% |
| 13 | Washington University in St. LouisSaint Louis, MO | $57.4M | +12.7% | 115 | 1.8% |
| 14 | Columbia University Health SciencesNew York, NY | $56.6M | −12.9% | 87 | 1.8% |
| 15 | Icahn School of Medicine at Mount SinaiNew York, NY | $56.5M | +18.3% | 83 | 1.8% |
| 16 | Yale UniversityNew Haven, CT | $56.3M | +13.3% | 105 | 1.8% |
| 17 | NYU Grossman School of MedicineNew York, NY | $55.2M | +3.5% | 71 | 1.8% |
| 18 | University of California, Los AngelesLos Angeles, CA | $52.0M | +11.3% | 85 | 1.7% |
| 19 | Duke UniversityDurham, NC | $50.1M | −2.0% | 92 | 1.6% |
| 20 | University of WashingtonSeattle, WA | $50.0M | −1.1% | 79 | 1.6% |
| 21 | Boston Children's HospitalBoston, MA | $48.6M | +22.2% | 62 | 1.6% |
| 22 | Cincinnati Children's Hospital Medical CenterCincinnati, OH | $47.8M | +5.7% | 69 | 1.5% |
| 23 | University of Alabama at BirminghamBirmingham, AL | $46.9M | +3.8% | 101 | 1.5% |
| 24 | Medical College of WisconsinMilwaukee, WI | $44.1M | +23.6% | 61 | 1.4% |
| 25 | The Ohio State UniversityColumbus, OH | $44.0M | +6.0% | 77 | 1.4% |
Showing the 25 largest of 244 institutions with NHLBI funding.
Open and upcoming NHLBI funding opportunities
NOFOs led by NHLBI first, then those NHLBI participates in, soonest due date first. Browse every NIH NOFO.
- Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)
RFA-HL-27-010 · K38
Next due Nov 9, 2026
- Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
PAR-27-011 · R61, R33
Next due Feb 1, 2027
- Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
PAR-27-012 · UG3, UH3
Next due Feb 1, 2027
- Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
PAR-27-013 · U24
Next due Feb 1, 2027
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
PAR-25-025 · R33
Next due Feb 3, 2027
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
PAR-25-026 · R61, R33
Next due Feb 3, 2027
- NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
PAR-25-447 · X01
Next due Feb 8, 2027
- Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
RFA-HL-27-004 · R03
Next due Feb 10, 2027
- Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
RFA-HL-26-016 · R33
Next due Feb 11, 2027
- Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
RFA-HL-26-017 · R61, R33
Next due Feb 11, 2027
Next due Feb 11, 2027
- Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
RFA-HL-26-019 · R61, R33
Next due Feb 11, 2027
- Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)
RFA-HL-26-020 · R33
Next due Feb 11, 2027
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
PAR-25-032 · R34
Next due Feb 16, 2027
- Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)
RFA-HL-26-012 · R38
Next due Oct 13, 2027
Showing 15 of 77. See all NHLBI NOFOs.
Recent NHLBI awards
The newest NHLBI award notices among the institutions above, each linked to its NIH RePORTER record.
- Discovery of exposome-associated asthma genetic variants and endotypes based on enhancer architecture (opens NIH RePORTER)
University of Kentucky · 1R01HL181559-01A1 · NHLBI · Notice Sep 18, 2026
$1.5MR01
- Regulation of vascular smooth muscle phenotype by TEADs (opens NIH RePORTER)
LSU Health Shreveport · 1R01HL176881-01A1 · NHLBI · Notice Sep 18, 2026
$709KR01
- Shortening the Diagnostic Odyssey for Children with Rare Pulmonary Diseases (RPD) (opens NIH RePORTER)
Boston Children's Hospital · 1R01HL181224-01A1 · NHLBI · Notice Sep 17, 2026
$2.7MR01
- Intermittent Hypoxemia in Early Life among Preterms (I-HELP) Sleep (opens NIH RePORTER)
Northwestern University · 1R01HL186511-01 · NHLBI · Notice Sep 17, 2026
$2.3MR01
- An integrative study of gene-by-sleep and activity behavior interactions for cardiovascular health (opens NIH RePORTER)
Brigham and Women's Hospital · 1R01HL187324-01 · NHLBI · Notice Sep 17, 2026
$1.5MR01
- Clinical-Molecular Endotypes of Primary Graft Dysfunction in Lung Transplant Patients (opens NIH RePORTER)
Northwestern University · 1R01HL187520-01 · NHLBI · Notice Sep 17, 2026
$1.3MR01
- BrighT STAR SIRIUS: a hybrid trial evaluating the impact of a comprehensive diagnostic stewardship toolkit on blood culture overuse in critically ill children (opens NIH RePORTER)
Children's Hospital of Philadelphia · 1R01HL183352-01A1 · NHLBI · Notice Sep 17, 2026
$1.1MR01
- Airway structure-immune cell relationships in allergic asthma (opens NIH RePORTER)
Massachusetts General Hospital · 1R01HL179235-01A1 · NHLBI · Notice Sep 17, 2026
$837KR01
- Promoting the Aortic Healing Response: A Novel Strategy to Stabilize the Aortic Wall and Prevent Dissection and Rupture (opens NIH RePORTER)
Baylor College of Medicine · 1R01HL189401-01 · NHLBI · Notice Sep 17, 2026
$816KR01
- Effects of Sleep Restriction on Glycemic Control and Cardiovascular Risk Mechanisms in Type 1 Diabetes Mellitus (opens NIH RePORTER)
Mayo Clinic Rochester · 1R01HL178855-01A1 · NHLBI · Notice Sep 17, 2026
$806KR01
Looking for a postdoc in heart, lung, and blood?
See how many heart, lung, and blood labs received a new NHLBI R01 or R00 in the last three months, by month, state, and institution.
Newly funded heart, lung, and blood labsQuestions about NHLBI funding
- How much does NHLBI fund?
- In fiscal year 2026, NHLBI administered $3.12B across 5,269 award records to the 244 institutions on this page. These are the recipients with $10M or more in total NIH funding, so the figure is a large share of NHLBI's extramural awards but not its full budget.
- Which institutions get the most NHLBI funding?
- University of Pittsburgh ($77.7M), University of Pennsylvania ($76.0M), Northwestern University ($75.5M) led NHLBI funding in FY2026.
- How do I find an open NHLBI funding opportunity?
- This page lists open and upcoming NOFOs where NHLBI is the lead or a participating institute, with the next due date. Most investigator-initiated applications go through the NIH parent announcements instead, and are assigned to an institute after submission; contact a NHLBI program officer before you apply to check fit.
More NIH funding rankings
By type
University and health systems
By NIH institute
All institutes · NCI · NIAID · NIA · NIGMS · NINDS · NIDDK · NIMH · OD · NICHD · NIDA · NCATS · NEI · NIAMS · NIEHS · NHGRI · NIAAA · NIDCD · NIDCR · NIBIB · NIMHD · NCCIH · NINR · NLM · FIC
By state
California · New York · Massachusetts · Pennsylvania · Texas · North Carolina · Maryland · Illinois · Washington · Ohio · Michigan · Florida · Missouri · Connecticut · Georgia · Minnesota · Tennessee · Wisconsin · Virginia · Colorado · New Jersey · Indiana · Oregon · Arizona · Alabama · Utah · Rhode Island · South Carolina · Kentucky · District of Columbia · Louisiana · Iowa · Oklahoma · Kansas · Nebraska · New Hampshire · New Mexico · Maine · Arkansas · Delaware · Mississippi · Vermont · Hawaii · Montana · West Virginia · Puerto Rico · South Dakota · Nevada · Idaho · North Dakota · Alaska · Wyoming